_________________________________________________________________________________ ASX Release Anatara Lifesciences 4C & Q4 FY26 Activities Report Highlights for the Quarter ending June 2026 • The research report on Anatara’s Anti-Obesity Project...
Quarterly Activities/Appendix 4C Cash Flow Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Anatara Lifesciences Ltd on 6ix
Earlier from Anatara Lifesciences
- Appendix 4D & Half Year Report 31 December 2025
- Company Update
- Anatara receives firm commitments for $1.2m Placement
- Trading Halt
- Response to ASX Price Query
Later from Anatara Lifesciences
- Appendix 4E & Financial Report 30 June 2026
- Conversion of Performance Rights and Cleansing Notice
- Application for quotation of securities - ANR
- Change of Director's Interest Notice
- Anatara receives $318,402 in R&D Tax Incentive for FY26
Follow Anatara Lifesciences into a list and get an email when it puts out news.
Follow Anatara Lifesciences